Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05869032Recruiting

Normative QEEG/ERP Data for Healthy Volunteers

Role: lead

NCT02769234Completed

EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)

Role: lead

NCT02187796Completed

Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic

Role: collaborator

NCT00938665Completed

Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.

Role: lead

NCT00582127Completed

Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.

Role: lead

All 5 trials loaded